Source:http://linkedlifedata.com/resource/pubmed/id/11069515
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2000-12-8
|
| pubmed:abstractText |
Photodynamic therapy (PDT) is a new modality involving the administration of a photosensitizer, or photosensitizer precursor, followed by its activation with light to generate a therapeutic effect. 5-Aminolaevulinic acid (ALA) is a photosensitizer precursor that is transformed by cells into protoporphyrin IX (PpIX), which can in turn be activated by red light.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0007-0963
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
143
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1032-5
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11069515-Adult,
pubmed-meshheading:11069515-Alopecia Areata,
pubmed-meshheading:11069515-Aminolevulinic Acid,
pubmed-meshheading:11069515-Dose-Response Relationship, Drug,
pubmed-meshheading:11069515-Female,
pubmed-meshheading:11069515-Hair,
pubmed-meshheading:11069515-Humans,
pubmed-meshheading:11069515-Male,
pubmed-meshheading:11069515-Middle Aged,
pubmed-meshheading:11069515-Photochemotherapy,
pubmed-meshheading:11069515-Photosensitizing Agents,
pubmed-meshheading:11069515-Treatment Failure
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata.
|
| pubmed:affiliation |
Division of Dermatology, Vancouver General Hospital and University of British Columbia, 835 West 10th Avenue, Vancouver, BC V5Z 4E8, Canada.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|